Best Chronic Disease Management Companies in United States
The 143 best Chronic Disease Management companies in United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: senseonics.
Tracking the best Chronic Disease Management companies in the United States by disclosed equity funding puts one name immediately out front: Senseonics, which accounts for all $96M of the total funding across 143 companies in our directory. That concentration is striking. Zero unicorns, a long tail of unfunded early-stage players, and one implantable glucose-monitoring specialist absorbing every disclosed dollar. The global chronic disease management market was valued at roughly $4.8B in 2023 and is forecast to hit $16.8B by 2033 at a 13.4% CAGR, so the funding gap between US startups and that opportunity is, honestly, enormous.
The sector is moving fast right now regardless of the funding picture. AI-driven care tools and tech-enabled remote monitoring are reshaping how clinicians manage everything from diabetes to cardiovascular conditions, and data security sits at the center of every compliance conversation as connectivity expands. If you're mapping this space to find your next partner or investment, the directory below gives you the clearest current snapshot of who's funded and who's gaining momentum.
Ranked: Best Chronic Disease Management companies in United States
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | senseonics Senseonics is a medical device startup company that focuses on the design, development, and commercialization… | $96M | 65 mo ago | Public | — | 1996 | Apple iCloud MailSalesforceMicrosoft ASP.NET+14 | 689 patents Implantable continuous glucose monitoring sensors and calibration/analytics algorithms | 4 job openings |
| 2 | a&d medical A&D Medical is a manufacturer and distributer of biometric monitoring solutions. | — | — | Private | — | 1977 | — | 547 patents Patents concentrated in health & consumer products | — |
| 3 | AandD Medical A&D Medical / LifeSource manufacturers blood pressure monitors and other home health care products for home… | — | — | — | — | — | — | — | 1 job opening · 1 launch |
| 4 | Activibe Developer of a medical web and mobile application intended to provide healthcare outcome tracking services. | — | — | Private | — | 2012 | — | — | — |
| 5 | Actuality Medical Developer of a spatial three-dimensional (3D) platform. | — | — | Acquired | — | 1997 | — | — | — |
| 6 | addicaid A data-driven addiction wellness platform for patients, payors, and providers. | — | — | Deadpooled | — | 2013 | — | — | — |
| 7 | Addiction Recovery Content saves lives - Addiction Recovery is a team of 40+ writers, averaging 5 years sober, creating… | — | — | — | — | 2014 | — | — | — |
| 8 | advanced health and performance institute Advanced Health and Performance Institute specializes in providing brain-mapping, neurofeedback research, and… | — | — | Private | — | 2011 | — | — | — |
Top 1 Chronic Disease Management companies in United States
#1
Public · Germantown, Maryland · founded 1996 · 121 employees$96.1Mraised▾
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Funding & investor landscape
Market landscape — 10 sub-themes by coverage
Share of Chronic Disease Management coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding flat · growth flat
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.